Emtricitabine Completed Phase N/A Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPreventionNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03012607Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV Therapy
NCT02449733Comprehensive HIV Prevention Package for MSM in Port Elizabeth
NCT01450189A Key Link for Transmission Prevention
NCT01253538Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
NCT04318210Open Label Extension (OLE) of the TDF2 Study, Botswana
NCT00608569Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
NCT01632995Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics
NCT00346567Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)
NCT02495779Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV